TCL Archive NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs June 15, 2012
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive “NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s September 20, 1991
TCL Archive In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm January 16, 1998
